Fund Holdings — Atlas Venture Life Science Advisors, LLC

Total Portfolio Value:
$865.15M
Total Bought:
$4.70M
Total Sold:
$146.30M
Net Transaction:
-$141.59M
Securities
▲▼
SharesValue
Q3 2025
▲▼
Q4 2025
▲▼
Change
▲▼
Q3 2025
▲▼
Q4 2025
▲▼
Weight (%)
▲▼
Change
▲▼
Kymera Therapeutics, Inc.(KYMR)4,896,4624,659,874-236,588$277.14M$362.58M41.91%+$85.45M
Dyne Therapeutics, Inc.(DYN)9,130,4659,130,4650$115.50M$178.59M20.64%+$63.09M
Sionna Therapeutics, Inc.(SION)3,615,5272,995,602-619,925$106.33M$123.24M14.24%+$16.91M
Disc Medicine, Inc.(IRON)2,142,6171,513,875-628,742$141.58M$120.22M13.90%-$21.37M
Day One Biopharmaceuticals, Inc.
COM
6,430,2576,412,560-17,697$45.33M$59.77M6.91%+$14.43M
Korro Bio, Inc.(KRRO)1,137,1491,137,1490$54.46M$9.11M1.05%-$45.35M
Q32 Bio Inc.(QTTB)2,092,1062,092,1060$4.14M$6.95M0.80%+$2.80M
Generation Bio, Co.0827,946+827,946$0$4.70M0.54%+$4.70M
Generation Bio, Co.827,9460-827,946$5.07M$0—-$5.07M
ImageneBio, Inc.(IMA)377,8140-377,814$3.08M$0—-$3.08M
Page 1 of 1